Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07128485 · ClinicalTrials.gov registry record · NA

Remote Intervention to Prevent Overdose

A NA study, sponsored by University of Alabama at Birmingham.

Not yet
Registry status
NA
Development phase
100
Enrollment target

NCT07128485 is a NA study that has not yet begun recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07128485, a NA study, has not yet begun recruiting, sponsored by University of Alabama at Birmingham.

NOT YET RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

This Type 1 hybrid effectiveness-implementation randomized controlled trial, Remote Fentanyl Test Strip Distribution and Education to Prevent Drug Overdose, aims to address the United States opioid crisis driven by fentanyl and other synthetic opioids by reducing overdose rates. It is supported by and included in the HEAL Initiative. This study would be the first national, fully remote trial to assess the impact of fentanyl test strips on overdose outcomes, using a novel 2x2 design crossing fentanyl test strip distribution and education to determine which approach most significantly reduces overdose rates while minimizing costs. This research will inform scalability around mail-based fentanyl test strip distribution and education programs to address the nation's opioid overdose crisis.

Interventions

  • OTHER Fentanyl test strips
  • BEHAVIORAL Fentanyl test strip education

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2027-01
Est. Completion 2027-11
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT07128485

The ClinicalTrials.gov registry entry for NCT07128485 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Fentanyl test strips is the first listed.

NCT07128485 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07128485 about?

NCT07128485 is a clinical study titled "Remote Intervention to Prevent Overdose". This Type 1 hybrid effectiveness-implementation randomized controlled trial, Remote Fentanyl Test Strip Distribution and Education to Prevent Drug Overdose, aims to address the United States opioid crisis driven by fentanyl and other synthetic opioids by reducing overdose rates. It is supported by a...

What is the current status of trial NCT07128485?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2027-01. Estimated completion is 2027-11.

What interventions are being tested in trial NCT07128485?

The interventions under investigation include: Fentanyl test strips (OTHER), Fentanyl test strip education (BEHAVIORAL).

Who is sponsoring clinical trial NCT07128485?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.